Infantile gastroenteritis and the resulting dehydrating diarrhoea is a major cause of morbidity in developed countries and of mortality in many developing countries. Since their original description in 1973, rotaviruses have emerged as the single most important cause of diarrhoea in infants and young children requiring admission to hospital for treatment of gastroenteritis.' A desire to reduce the significant morbidity associated with rotaviruses led to the development of a live attenuated vaccine,2 recently made available for trials in this country. Concurrently, advances in adequate typing systems allowing characterisation of virus from different geographic areas and from sequential infections in populations followed longitudinally have increased our understanding of the epidemiology of this most important group of viruses.3 Knowledge of the epidemiology of rotavirus would be important in the planning of any vaccine programme contemplated for this country.
The gastroenteritis associated with rotavirus has consistently been described as more severe than that caused by other agents. The pathophysiology is felt to be loss of absorptive capacity in the small intestine. The incubation period is 48 hours, with viral excretion preceding the onset of symptoms. There is often early vomiting followed by explosive and watery diarrhoea lasting 5-7 days. Virus is usually shed from the 3rd-8th days. Although IgM antibody appears on the 5th day and stays elevated for about three weeks, IgG antibody does not appear until 2-4 weeks after infection.4
Cross-sectional seroepidemiological surveys have shown high antibody levels in the newborn (due to transfer ofpassive antibody from mother), falling over the first six months of life, peaking again from 2-3 years. High geometric mean titres are then maintained until the age of40 when levels begin a gradual decline.5
Children aged 6-24 months seem most susceptible to clinical illness following rotavirus infection with peak incidence in most series at [9] [10] [11] [12] Rotavirus was implicated in 50% of hospitalised episodes of diarrhoea in children under the age of two.6 A prospective study from Copenhagen similarly found rotavirus to be the most frequent pathogen in children hospitalised with gastroenteritis. Incidence was highest under the age of 12 months, with twice as many cases between 6-12 as between 0-6 months.7
Both series noted a decline in incidence of hospitalisation and outpatient visits with age, and a predominance of males among hospitalised patients.
Transmission of rotaviruses is assumed to be fecaloral and probably varies with climate, population density and local habits. In temperate climates, rotavirus gastroenteritis peaks in the cooler months, as illustrated by the series from Copenhagen where 85% of isolations occurred from January-April. A similar seasonal trend was noted in Tecumseh.8 In contrast, this virus is seen year round in most tropical climates.'
In prospective follow-up of children from 20 daycare centres in Houston, rotavirus was recovered exclusively from children under the age of 3, with a secondary attack rate of 15%.9 A subsequent prospective study in Arizona day-care centres found rotavirus significantly more often in children under 12 months, compared to those 13-36 months of age (p < 0.001).10 Intra-familial transmission was emphasised by a series from New Zealand: 28 families exposed to a child with rotavirus were studied prospectively. 75% of siblings under the age of 12 [8] [9] [10] [11] months during an epidemic of subgroup 2 virus in Tampere showed 88% efficacy against natural challenge by wild rotavirus. 22 The same investigators then showed that seroconversion could be increased to 88% by simple milk feeding vaccination. 23 Although the results from Finland are promising and show that the vaccine is safe and appears to be effective,24 rotavirus vaccine trials in this country must address the efficacy in our population. The aim would be a small-scale field trial to evaluate efficacy in the target population: children between the ages of 9 months and 2 years. Knowing the seasonal pattern of rotavirus isolations in this country it would be possible to time the trials to coincide with the beginning of the epidemic season (weeks 37-40) to provide optimum challenge from wild virus.
In the last epidemic year in England and Wales at least 5800 infants and children under the age of 5 were affected by the diarrhoea, dehydration and discomfort of rotaviruses. Although precise data on numbers of hospitalisations are not available, extrapolating from prospective series in other countries suggests that the burden upon the health service would have been significant. Rotavirus vaccine presents an exciting ,prospect for reducing this morbidity. What is known about the epidemiology of rotaviruses, coupled with the results of the current vaccine trials, can be used to (1) predict the effect introduction of vaccine might have on the pattem of disease in our population, (2) construct a balance sheet for evaluating the vaccine, and if appropriate (3) guide the planning of a sensible vaccine programme.
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